The state-of-the-art API plant manufactures wide range of APIs across various therapeutic areas. The plant complies with the International Conference on Harmonization (ICH) and Schedule M guidelines in the area of API manufacturing.

Various critical reactions like Oxidation, Chlorination etc. are carried out under strict cGMP and Safety compliance. The plant has implemented various energy conservation projects to reduce energy intensity and minimize the carbon footprint. The Company’s core competence in manufacturing is due to its constant efforts to update processes, implement safety measures and focus on consistency in product quality. To meet the increasing demand for APIs in the future, we are multiplying our efforts and gearing up to deliver uncompromising quality in the most cost effective way.

The API plant has both dedicated and Multiproduct production lines and is well-equipped to minimize exposure to both Product and Personnel.